Smoking Cessation Intervention for HIV/AIDS
Trial Summary
What is the purpose of this trial?
This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
Do I have to stop taking my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but it does require that you are already receiving antiretroviral therapy for HIV. You cannot be receiving any other smoking cessation interventions currently or within the prior 30 days.
What data supports the effectiveness of this treatment for smoking cessation in individuals with HIV/AIDS?
Episodic future thinking (EFT) has shown promising results in reducing cigarette demand among individuals with substance use disorders, which may be relevant for those with HIV/AIDS who also smoke. Additionally, smoking cessation is crucial for improving the health of individuals with HIV, as smoking-related health risks are significant in this population.12345
Is episodic future thinking (EFT) safe for use in smoking cessation interventions?
How is the Smoking Cessation Intervention for HIV/AIDS different from other treatments?
Eligibility Criteria
This trial is for HIV-positive adults aged 45-80 who smoke and meet criteria for lung cancer screening. They must understand the study, consent to participate, have a compatible smartphone, and not be pregnant or breastfeeding. Exclusions include recent CT scans, history of lung cancer, serious infections, or other health issues that could affect participation.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the smartphone application, Positively Smoke Free - Mobile, for 42 days and receive nicotine replacement therapy for 12 weeks. Within 60 days of study registration, patients undergo LDCT.
Follow-up
Participants are monitored for smoking cessation and adherence to interventions at 3, 6, and 12 months.
Treatment Details
Interventions
- Nicotine Replacement (Nicotine Replacement)
- Smoking Cessation Intervention (Behavioural Intervention)